- +1 (209) 605-6737
Medically reviewed by Jeff Steckler, OTD, OTR/L – Doctor of Occupational Therapy with 38+ years of clinical experience and former U.S. Army medic. Last reviewed March 26, 2026.
Arthritis Treatment & Recovery in Modesto: Your Complete Guide
If you are searching for effective arthritis treatment near Modesto, Advanced Recovery Cryotherapy offers the most comprehensive, evidence-based approach in the Central Valley. Using Class IV laser therapy, whole body cryotherapy, localized cryotherapy, compression therapy, cupping, and multiple complementary modalities, Dr. Jeff Steckler designs personalized protocols that reduce arthritis pain, decrease joint inflammation, and restore function – without surgery or pharmaceutical dependence. The CDC reports that 53.2 million American adults have doctor-diagnosed arthritis – nearly 1 in 4. If arthritis is affecting your quality of life, you are not alone, and effective treatment is available right here in Modesto.
What You Will Learn in This Guide
This comprehensive arthritis treatment guide covers everything you need to make informed decisions about managing your condition:
- The four major types of arthritis – osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and gout – and how each affects your joints differently
- Why a multi-modality approach outperforms single treatments for arthritis pain and inflammation
- The clinical evidence supporting Class IV laser therapy as a primary arthritis treatment, including landmark studies from 2024
- How cryotherapy reduces arthritis inflammation and pain through specific biological mechanisms
- Personalized recovery protocols for knee OA, hip arthritis, hand and wrist RA, and shoulder arthritis
- Answers to the 8 most common questions arthritis patients ask, with specific research citations
- What to expect at your first visit and how to get started with treatment
Why Arthritis Treatment Matters in the Central Valley
Arthritis is not just a condition – it is the number one cause of disability in America, according to the Arthritis Foundation, costing the U.S. economy $303.5 billion annually in medical costs and lost wages. And in the Central Valley, the impact is particularly severe.
Stanislaus County has a population of approximately 550,000 residents, and using the CDC’s national prevalence rate of nearly 1 in 4 adults, an estimated 117,000 adults in Stanislaus County alone are living with some form of arthritis. The Central Valley’s economic profile amplifies this burden. Agricultural workers, warehouse employees, manufacturing laborers, and construction workers – the backbone of the regional economy – subject their joints to repetitive stress, heavy loading, and physical demands that accelerate joint degeneration. Decades of this work-related joint stress produce osteoarthritis rates that exceed national averages.
The demographic composition of the Central Valley adds another dimension. The region’s growing population of adults over 50 faces the natural age-related increase in arthritis prevalence, while the significant Hispanic and Latino community faces genetic predisposition to certain arthritis types combined with historically limited access to specialized joint care. Many Central Valley residents have relied on over-the-counter pain medications, occasional corticosteroid injections, and the hope that rest would eventually help – approaches that manage symptoms but do not address the underlying joint deterioration.
This gap in comprehensive arthritis care is precisely what Advanced Recovery Cryotherapy was designed to fill. Dr. Jeff Steckler’s 38+ years of clinical experience as a Doctor of Occupational Therapy – combined with his background as a U.S. Army medic treating musculoskeletal injuries in demanding conditions – gives him an unmatched understanding of how arthritis affects real people in physically demanding lives. His approach goes beyond pain management to address the biological processes driving joint inflammation, cartilage degradation, and functional loss.
ARC’s multi-modality facility provides access to treatments that were previously available only at elite sports medicine centers and university research hospitals. Class IV laser therapy, whole body cryotherapy, localized cryotherapy, NormaTec compression, cupping therapy, Graston technique, infrared therapy, assisted stretching, and more – all under one roof, all directed by a clinician with the expertise to know exactly which combination of modalities each arthritis patient needs.
The research is clear: arthritis responds best to comprehensive, multi-modality treatment that addresses inflammation, pain, joint mechanics, and tissue repair simultaneously. A 2025 meta-analysis in the Journal of Clinical Medicine confirmed that cryotherapy produces significant pain reduction (standardized mean difference = -0.57) in knee osteoarthritis – and when combined with Class IV laser and other modalities, outcomes improve further. At ARC, every arthritis patient receives a protocol built on this evidence, personalized to their specific type of arthritis, affected joints, and treatment goals.
Whether you have been recently diagnosed or have lived with arthritis for decades, whether you have knee pain, hip stiffness, hand and wrist limitations, or shoulder restrictions – ARC provides the advanced treatment options and clinical expertise to help you take control of your condition rather than letting it control you.
Understanding Arthritis: Types, Mechanisms, and How Each Affects Your Joints
Arthritis is not a single disease – it is a family of more than 100 conditions that all involve joint inflammation and damage, but through very different mechanisms. Understanding your specific type of arthritis is critical because it determines which treatment approach will be most effective. At ARC, Dr. Steckler begins every arthritis patient’s journey with a thorough assessment to identify the precise type and stage of arthritis involved.
Osteoarthritis (OA) – The Most Common Type
Osteoarthritis is a degenerative joint disease that affects more people worldwide than any other musculoskeletal condition. The Lancet’s 2020 Global Burden of Disease study reported that knee osteoarthritis alone affects 365 million people globally, making it one of the most prevalent health conditions on earth. In the United States, the CDC estimates that 32.5 million adults have OA.
OA occurs when the articular cartilage that cushions the ends of bones within a joint progressively wears down. This cartilage, which is smooth and slippery in healthy joints, becomes rough, thin, and eventually wears away completely in advanced cases – leaving bone grinding against bone. The process involves both mechanical wear-and-tear and an active inflammatory component: as cartilage breaks down, debris particles trigger inflammatory cytokine release in the joint capsule, creating a destructive cycle of degeneration and inflammation.
The joints most commonly affected by OA include knees (the most common site), hips, hands and finger joints, spine (cervical and lumbar), shoulders, and the base of the thumb. Risk factors include age (prevalence increases significantly after 45), previous joint injury, occupational joint stress, obesity, and genetic predisposition.
OA symptoms develop gradually and include joint pain during or after activity, stiffness after inactivity (especially morning stiffness lasting less than 30 minutes), joint swelling, decreased range of motion, crepitus (grinding or popping sounds), and eventual loss of function.
Rheumatoid Arthritis (RA) – The Autoimmune Type
Rheumatoid arthritis is fundamentally different from osteoarthritis. It is an autoimmune disease in which the body’s immune system mistakenly attacks the synovial membrane – the thin tissue lining the inside of the joint capsule. This autoimmune attack produces chronic inflammation that gradually destroys cartilage, bone, and supporting structures within affected joints.
RA affects approximately 1.3 million Americans and is 2-3 times more common in women than men. Unlike OA, which develops gradually from wear and tear, RA can strike at any age and often appears between ages 30-60. It typically affects joints symmetrically (both hands, both wrists, both knees) and frequently involves the small joints of the hands and feet first.
The inflammatory process in RA is driven by an overproduction of pro-inflammatory cytokines, particularly TNF-alpha and IL-6. These cytokines recruit immune cells to the joint, produce an inflamed, thickened synovial membrane called pannus, and gradually erode cartilage and bone. This is why both pharmaceutical treatments (biologics targeting TNF-alpha and IL-6) and non-pharmaceutical treatments like WBC (which reduces circulating TNF-alpha and IL-6) can be effective for RA.
Psoriatic Arthritis (PsA)
Psoriatic arthritis occurs in approximately 30% of people with psoriasis – the autoimmune skin condition characterized by scaly, itchy patches. PsA can affect any joint and causes pain, stiffness, and swelling. It often involves the fingers and toes (causing “sausage digits” or dactylitis), the spine, and the entheses – the points where tendons and ligaments attach to bone.
Like RA, PsA involves an autoimmune inflammatory process, but with distinct patterns of joint involvement and an association with skin and nail changes. Treatment approaches at ARC overlap with RA protocols but are adjusted based on the specific joints and entheses involved.
Gout
Gout is a form of inflammatory arthritis caused by the crystallization of uric acid in joint fluid. These needle-sharp monosodium urate crystals trigger an intense, acute inflammatory response that produces severe pain, redness, warmth, and swelling – most commonly in the big toe (first metatarsophalangeal joint), but also in ankles, knees, wrists, and fingers.
Gout flares are among the most painful joint conditions patients experience. During an acute flare, localized cryotherapy at ARC provides rapid inflammation and pain reduction by cooling the affected joint, reducing the inflammatory cytokine storm triggered by the crystals, and decreasing nerve conduction velocity for immediate pain relief.
“The biggest mistake I see in arthritis treatment is a one-size-fits-all approach. Osteoarthritis responds primarily to laser therapy and targeted joint protocols because the underlying problem is cartilage degeneration and localized inflammation. Rheumatoid arthritis requires whole body cryotherapy as a primary modality because the underlying problem is a systemic autoimmune response driving circulating TNF-alpha and IL-6. Treating RA the same way you treat OA leaves half the problem unaddressed. With 38 years of clinical experience and 16+ modalities available, I can match the right protocol to the right type of arthritis every single time.” – Jeff Steckler, OTD, OTR/L
Arthritis Prevalence in California
The California Department of Public Health reports that 26% of California adults have arthritis, representing millions of residents statewide. In the Central Valley, prevalence rates are estimated to be even higher due to the region’s concentration of physically demanding occupations, aging population demographics, and historically limited access to advanced joint care. This makes comprehensive arthritis treatment facilities like ARC essential community health resources.
Why Multi-Modality Treatment Outperforms Single Approaches for Arthritis
Arthritis is a multi-dimensional condition. It involves inflammation, pain signaling, cartilage and bone changes, muscle weakness, fascial restrictions, impaired circulation, and progressive loss of joint mechanics. No single treatment can address all of these dimensions simultaneously – which is why single-modality approaches (taking NSAIDs alone, getting occasional cortisone shots, or applying ice packs) consistently produce incomplete results.
A landmark 2025 meta-analysis published in the Journal of Clinical Medicine confirmed that cryotherapy produces significant pain reduction (standardized mean difference = -0.57) in knee osteoarthritis. But the same body of research demonstrates that outcomes improve substantially when cryotherapy is combined with other evidence-based modalities that target different aspects of the arthritis disease process.
At ARC, Dr. Steckler’s multi-modality approach works because each treatment targets a different mechanism of arthritis:
- Class IV laser therapy addresses cartilage repair, deep tissue inflammation, and cellular regeneration
- Whole body cryotherapy reduces systemic inflammatory cytokines and provides endorphin-mediated pain relief
- Localized cryotherapy delivers targeted inflammation reduction to specific affected joints
- Compression therapy clears joint effusion and inflammatory waste through lymphatic drainage
- Cupping therapy breaks fascial adhesions around arthritic joints and increases local blood flow
- Graston/IASTM addresses scar tissue and tissue restrictions that limit joint mobility
By combining these modalities in carefully sequenced protocols, ARC treats the complete arthritis picture – not just one symptom at a time. The following sections detail each primary modality and the clinical evidence supporting its use for arthritis.
Class IV Laser Therapy for Arthritis: The Primary Modality
Class IV laser therapy (high-intensity photobiomodulation) is the primary treatment modality for arthritis at ARC, particularly for osteoarthritis. The reason is simple: among all available non-surgical arthritis treatments, Class IV laser has the strongest and most current evidence base for producing lasting improvements in pain, function, and joint health.
How Class IV Laser Therapy Works for Arthritis
Class IV laser therapy delivers high-powered light energy at specific therapeutic wavelengths (typically 808nm and 980nm) that penetrate deep into joint tissue – reaching cartilage, synovial membrane, subchondral bone, and surrounding soft tissue structures. When this photon energy is absorbed by cells, it triggers a cascade of beneficial biological responses:
Mitochondrial activation: Photon energy is absorbed by cytochrome c oxidase in cellular mitochondria, the energy-producing organelles in every cell. This dramatically increases adenosine triphosphate (ATP) production – the energy currency that fuels cellular repair, regeneration, and anti-inflammatory responses. In arthritic joints where cells are energy-depleted and struggling to maintain tissue integrity, this ATP boost can be transformative.
Anti-inflammatory cytokine modulation: Class IV laser reduces the production of inflammatory mediators including prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), and pro-inflammatory interleukins at the treatment site. Simultaneously, it promotes the release of anti-inflammatory mediators. This dual action mirrors the effects of NSAIDs and COX-2 inhibitors but without systemic side effects.
Microcirculation enhancement: Laser therapy promotes angiogenesis (new blood vessel formation) and vasodilation in treated tissue, increasing blood flow to the joint. Improved circulation delivers more oxygen, nutrients, and anti-inflammatory mediators to the joint while clearing inflammatory waste products more efficiently.
Chondrocyte stimulation: Emerging research suggests that photobiomodulation can stimulate chondrocyte activity – the cells responsible for maintaining and repairing articular cartilage. While this does not reverse advanced cartilage loss, it may slow cartilage degradation and support partial repair in early-to-moderate OA.
Nerve modulation: Laser therapy affects peripheral nerve function, reducing pain signal transmission and increasing the pain threshold in treated tissue. This provides analgesic effects that complement the anti-inflammatory benefits.
Clinical Evidence for Class IV Laser and Arthritis
The evidence supporting Class IV laser for arthritis is among the strongest in the rehabilitation literature:
- Alayat et al. (2024) – This recent study found that high-intensity laser therapy produces the best long-term outcomes for osteoarthritis, with sustained improvements in pain scores, functional capacity, and quality of life measures that persisted beyond the active treatment period. This long-term benefit distinguishes laser therapy from treatments that provide only temporary relief.
- Angelova and Ilieva (2016) – Published in the journal Rheumatology International (PMID: 27056423), this research demonstrated strong analgesic effects of high-intensity laser therapy for knee osteoarthritis. Patients experienced significant pain reduction measured by both visual analog scale (VAS) and WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scores.
- Kheshie et al. (2014) – Published in Lasers in Medical Science (PMID: 24500335), this comparative study confirmed that high-intensity laser therapy (Class IV) produces superior outcomes compared to low-level laser therapy (Class III) for knee OA. The higher power of Class IV lasers enables deeper tissue penetration and more effective photobiomodulation of joint structures, translating to better clinical outcomes.
Why Class IV Laser Is ARC’s Primary Arthritis Modality
Dr. Steckler positions Class IV laser as the foundation of most arthritis protocols at ARC for several reasons: it addresses the condition at the cellular level rather than just managing symptoms; it has the strongest evidence base for long-term outcomes; it is completely non-invasive and painless; it complements every other modality ARC offers; and it can be precisely calibrated for different joint sizes, arthritis severity levels, and tissue depths. For most arthritis patients, the treatment plan begins with Class IV laser and builds additional modalities around it based on individual needs.
Cryotherapy for Arthritis: Whole Body and Localized Approaches
Cryotherapy is ARC’s second most important modality for arthritis treatment, serving as a powerful complement to Class IV laser therapy. Both whole body cryotherapy and localized cryotherapy play distinct roles in arthritis management, and Dr. Steckler uses them strategically based on arthritis type and presentation.
Whole Body Cryotherapy for Arthritis
Whole body cryotherapy (WBC) involves exposure to temperatures between -180 and -240 degrees Fahrenheit for 2-3 minutes. For arthritis patients, WBC provides two critical benefits:
Systemic inflammatory cytokine reduction: WBC decreases circulating levels of TNF-alpha, IL-6, and other pro-inflammatory cytokines throughout the body. This is particularly important for rheumatoid arthritis and psoriatic arthritis, where the inflammatory process is systemic – driven by an overactive immune system producing inflammatory mediators that attack joints throughout the body. By reducing these circulating cytokines, WBC addresses the root cause of autoimmune joint destruction, not just the symptoms at individual joints.
Endorphin-mediated pain relief: The extreme cold stimulus triggers a massive endorphin and enkephalin release, providing natural pain relief that can last for hours after treatment. For arthritis patients dealing with chronic pain, this endorphin cascade offers meaningful relief without the risks associated with opioid pain medications.
Localized Cryotherapy for Arthritis
Localized cryotherapy targets individual arthritic joints with concentrated cold at approximately -40 degrees Fahrenheit for 5-10 minutes per joint. Its advantages for arthritis include:
Targeted joint inflammation reduction: Intense localized vasoconstriction reduces blood flow to the inflamed joint capsule, immediately decreasing the delivery of inflammatory mediators and reducing joint swelling. This is particularly effective for knee OA, the most common form of arthritis, where visible swelling reduction can occur within minutes of treatment.
Joint effusion management: Many arthritic joints develop effusion – excess fluid accumulation within the joint capsule. Localized cryotherapy, followed by compression therapy, helps mobilize and clear this excess fluid, reducing the pressure and pain that effusion causes.
Nerve conduction velocity reduction: Localized cooling reduces the speed at which pain signals travel from the arthritic joint to the brain, providing immediate analgesic effects at the treatment site.
Clinical Evidence for Cryotherapy and Arthritis
- Guillot et al. (2014) – Published in Joint Bone Spine (PMID: 24962568), this study specifically examined cryotherapy for inflammatory rheumatic diseases including rheumatoid arthritis. The researchers found significant pain reduction and functional improvement following cryotherapy protocols, with benefits that were clinically meaningful and well-tolerated by patients with active autoimmune joint disease.
- Samuels et al. (2021) – This research demonstrated that cryotherapy reduces inflammation, edema, and oxidative stress in arthritic joints. The study confirmed that cryotherapy’s anti-inflammatory effects extend beyond symptom relief to address the underlying oxidative damage that contributes to cartilage degradation in arthritis.
How Dr. Steckler Combines Cryotherapy with Laser for Arthritis
The most effective arthritis protocols at ARC combine Class IV laser and cryotherapy in a strategic sequence. A typical session begins with Class IV laser therapy to deliver photobiomodulation energy to the affected joints, stimulating cellular repair and reducing inflammatory mediators at the tissue level. This is followed by either WBC (for RA, PsA, or multi-joint OA) or localized cryotherapy (for single-joint OA or gout) to provide additional anti-inflammatory and analgesic effects through cold-mediated mechanisms. The two modalities target inflammation through completely different biological pathways – photon energy vs. cold exposure – creating a synergistic effect that exceeds what either treatment achieves alone.
Compression Therapy and Cupping for Arthritic Joints
Compression Therapy for Arthritis
NormaTec compression therapy plays a critical supporting role in arthritis treatment by addressing one of the most common and debilitating symptoms: joint swelling and effusion. Many arthritis patients – particularly those with knee OA, ankle arthritis, and RA affecting the lower extremities – develop chronic edema that contributes to pain, stiffness, and limited range of motion.
NormaTec’s sequential pneumatic compression delivers pulsating pressure patterns that physically mobilize fluid from swollen joints and surrounding tissue into the lymphatic system for clearance. This mechanical fluid management accomplishes what the body’s impaired lymphatic function cannot do efficiently in chronically inflamed joints.
Sari et al. (2019) demonstrated that intermittent pneumatic compression produces superior outcomes compared to cold packs alone for inflammation and edema reduction. For arthritis patients, this translates to faster swelling reduction, more immediate range of motion improvement, and enhanced effectiveness of other treatments (cryotherapy and laser work better on joints that are not severely edematous).
At ARC, compression therapy is typically sequenced after cryotherapy: WBC or localized cryo first reduces inflammatory cytokines and causes vasoconstriction, then compression therapy flushes the mobilized inflammatory waste and excess fluid through the lymphatic system. This one-two approach produces more complete and longer-lasting swelling reduction than either treatment alone.
Cupping Therapy for Arthritis
Cupping therapy addresses an often-overlooked component of arthritis pain: the fascial restrictions and soft tissue adhesions that develop around arthritic joints. As arthritis progresses, the muscles, tendons, fascia, and ligaments surrounding affected joints become tight, restricted, and adhesed. These tissue changes contribute significantly to pain and loss of mobility but are not addressed by anti-inflammatory treatments alone.
Cupping uses suction to lift and separate tissue layers, breaking fascial adhesions, increasing local blood flow by 300-400%, and creating space for improved joint mechanics. For arthritis patients, this translates to improved range of motion, decreased peri-articular muscle tension, and enhanced delivery of oxygenated blood to the joint environment.
Li et al. (2017) – Published in Evidence-Based Complementary and Alternative Medicine (PMID: 29317898), this systematic review found that cupping therapy produces significant improvements in WOMAC scores (the gold-standard measure of arthritis symptoms) for osteoarthritis patients. The improvements were clinically meaningful and sustained, indicating that cupping addresses structural components of arthritis pain that persist between anti-inflammatory treatments.
Dr. Steckler applies cupping strategically around arthritic joints – on the quadriceps, hamstrings, and IT band surrounding an arthritic knee, for example, or on the rotator cuff muscles and deltoid surrounding an arthritic shoulder. By releasing these peri-articular soft tissue restrictions, he creates better biomechanical conditions for the joint to function, reducing compensatory stress patterns that accelerate arthritis progression.
Additional Arthritis Treatment Modalities at ARC
Beyond the primary modalities of Class IV laser, cryotherapy, compression, and cupping, Advanced Recovery Cryotherapy offers several additional treatments that Dr. Steckler incorporates into arthritis protocols based on individual patient needs.
Graston Technique / IASTM for Arthritis
Graston technique and instrument-assisted soft tissue mobilization (IASTM) use specialized stainless steel instruments to detect and treat fascial restrictions, scar tissue, and adhesions in the soft tissue structures surrounding arthritic joints. For arthritis patients, these tissue restrictions are both a consequence and an accelerator of the disease: arthritis causes protective muscle guarding and fascial tightening, which alters joint mechanics, increases stress on already-damaged cartilage, and accelerates degeneration.
Dr. Steckler’s expertise as an occupational therapist makes his application of IASTM particularly effective. His advanced understanding of joint biomechanics allows him to identify the specific tissue restrictions that are creating compensatory stress patterns and contributing to each patient’s pain and functional limitations. By addressing these restrictions, IASTM restores more normal joint mechanics that reduce cartilage loading and slow disease progression.
Infrared Cocoon for Arthritis Stiffness
The infrared cocoon delivers deep tissue heating through far-infrared wavelengths, which is particularly beneficial for the joint stiffness that is one of arthritis’s most disabling symptoms. Morning stiffness, post-inactivity stiffness, and cold-weather stiffness are common complaints among arthritis patients that significantly limit daily function.
Infrared heat penetrates deeply into joint tissue, increasing synovial fluid viscosity (making it more lubricating), relaxing periarticular muscles and tendons, improving local blood flow, and activating heat shock proteins that protect joint cells from inflammatory damage. Many arthritis patients at ARC use infrared cocoon sessions on alternating days with cryotherapy, creating a therapeutic contrast between cold-mediated anti-inflammatory effects and heat-mediated joint lubrication and flexibility.
Assisted Stretching for Arthritis Range of Motion
Loss of range of motion is one of the most functionally limiting consequences of arthritis. As joint inflammation and cartilage changes progress, the surrounding muscles, tendons, and joint capsule tighten, progressively restricting how far the joint can move. This range of motion loss affects every daily activity – bending to tie shoes, reaching overhead, climbing stairs, gripping objects.
ARC offers assisted stretching protocols specifically designed for arthritic joints. After the joint has been treated with laser therapy (to reduce inflammation and pain at the tissue level) and cryotherapy (to provide analgesic effects), Dr. Steckler guides gentle, progressive stretching to maintain and gradually improve range of motion. This post-treatment stretching window – when inflammation is reduced and pain thresholds are elevated – allows patients to achieve greater range of motion gains with less discomfort than stretching alone.
BrainTap Neurofeedback for the Arthritis Pain-Stress Cycle
Chronic arthritis pain creates a vicious neurological cycle: pain increases stress, stress amplifies pain perception through central sensitization, heightened pain perception increases stress further. BrainTap neurofeedback interrupts this cycle by training the brain to downregulate its stress response and reduce the central amplification of pain signals. While not a direct arthritis treatment, BrainTap can improve treatment outcomes by reducing the neurological component of chronic arthritis pain. Many ARC patients incorporate BrainTap sessions as part of their overall arthritis management plan.
Arthritis Recovery Protocols and Treatment Comparison
Dr. Steckler designs every arthritis protocol based on the specific type of arthritis, the joints affected, the severity of degeneration or inflammation, the patient’s functional goals, and their response to treatment. Below are four of ARC’s most commonly prescribed arthritis protocols.
Protocol 1: Knee Osteoarthritis
Condition: Degenerative knee OA (most common arthritis presentation at ARC)
Protocol: Class IV laser therapy on the knee joint (10-15 min, targeting medial and lateral joint lines, patellofemoral joint, and surrounding soft tissue) followed by localized cryotherapy on the knee (8 min) followed by compression therapy on the full lower extremity (20 min). Cupping on quadriceps, hamstrings, and IT band every other session. Assisted stretching for knee flexion and extension ROM at the end of each visit.
Frequency: 3 sessions per week for 6 weeks, then 1-2 weekly maintenance.
Expected outcomes: Significant pain reduction by week 2-3. Improved range of motion by week 3-4. Measurable functional improvement (stair climbing, walking distance, sit-to-stand) by week 4-6.
Protocol 2: Hip Arthritis
Condition: Hip OA or post-surgical hip inflammation
Protocol: Class IV laser therapy on the hip joint (12-15 min, targeting anterior, lateral, and posterior hip structures) followed by WBC (3 min, for systemic anti-inflammatory effects and deep hip joint access through systemic cooling) followed by compression therapy (20 min). Graston/IASTM on hip flexors, glutes, piriformis, and IT band every other session. Assisted stretching for hip flexion, extension, abduction, and rotation.
Frequency: 3 sessions per week for 6 weeks, then 1-2 weekly maintenance.
Expected outcomes: Pain reduction beginning by week 2. Improved walking gait and stride length by week 3-4. Increased hip ROM and decreased compensatory back pain by week 4-6.
Protocol 3: Hand and Wrist Rheumatoid Arthritis
Condition: RA affecting the small joints of the hands, wrists, and fingers
Protocol: WBC (3 min, as the primary systemic anti-inflammatory treatment targeting circulating TNF-alpha and IL-6) followed by Class IV laser therapy on individual hand and wrist joints (8-10 min, targeting MCP, PIP, and DIP joints plus wrist) followed by localized cryotherapy on the most swollen joints (5 min each). Paraffin wax or infrared cocoon on alternating days for stiffness management. Gentle assisted stretching for finger and wrist ROM.
Frequency: 3-4 sessions per week during active RA flares, 2-3 sessions per week during moderate disease activity, 1-2 sessions per week for maintenance.
Expected outcomes: Reduced morning stiffness by week 1-2. Decreased joint swelling by week 2-3. Improved grip strength and hand function by week 4-6. Reduced flare severity with ongoing maintenance.
Protocol 4: Shoulder Arthritis
Condition: Glenohumeral OA, acromioclavicular joint arthritis, or post-surgical shoulder inflammation
Protocol: Class IV laser therapy on the shoulder (12 min, targeting the glenohumeral joint, AC joint, rotator cuff, and subacromial space) followed by localized cryotherapy on the shoulder (8 min) followed by cupping on the rotator cuff, deltoid, and upper trapezius. Graston/IASTM on the shoulder capsule and surrounding fascia as needed. Assisted stretching for shoulder flexion, abduction, external and internal rotation.
Frequency: 3 sessions per week for 6 weeks, then 1-2 weekly maintenance.
Expected outcomes: Reduced shoulder pain at rest by week 2. Improved active ROM by week 3-4. Decreased night pain (a hallmark of shoulder arthritis) by week 3-4. Improved overhead function by week 5-6.
Treatment Comparison Table
| Treatment | Best Arthritis Type | Mechanism | Duration | Evidence Level |
|---|---|---|---|---|
| Class IV Laser | OA (primary), all types | Photobiomodulation, cellular repair, cartilage support, anti-inflammatory | 10-15 min per joint | Strong (2024 studies, multiple RCTs) |
| Whole Body Cryo | RA, PsA, multi-joint OA | Systemic cytokine reduction, endorphin release, norepinephrine surge | 2-3 minutes | Strong (Guillot 2014, Samuels 2021) |
| Localized Cryo | Single-joint OA, gout flares | Targeted vasoconstriction, nerve conduction reduction, effusion management | 5-10 min per joint | Strong (systematic reviews) |
| Compression | All types with edema | Lymphatic drainage, effusion clearance, venous return | 20-30 minutes | Strong (Sari 2019) |
| Cupping | OA with fascial restrictions | Fascial release, blood flow increase, WOMAC improvement | 15-20 minutes | Moderate-Strong (Li 2017) |
| Graston / IASTM | All types with tissue restrictions | Scar tissue breakdown, fascial release, biomechanical restoration | 10-15 min per area | Moderate (clinical studies) |
| Infrared Cocoon | All types with stiffness | Deep heating, synovial viscosity improvement, HSP activation | 30-45 minutes | Moderate (clinical studies) |
“After 38 years of treating musculoskeletal conditions, I can tell you this: arthritis patients who follow a structured, multi-modality protocol consistently achieve outcomes that surprise their orthopedic surgeons. I have had patients come in expecting to schedule knee replacement surgery within the year, and after 6-8 weeks of laser, cryo, compression, and cupping, their pain and function improved to the point where surgery was no longer on the table. That does not happen with every patient, but it happens often enough that I believe every arthritis patient deserves to try comprehensive non-surgical treatment before committing to a joint replacement.” – Jeff Steckler, OTD, OTR/L
Frequently Asked Questions About Arthritis Treatment
Is cryotherapy good for arthritis?
Yes – clinical research strongly supports cryotherapy as an effective treatment for arthritis. Guillot et al. (2014) demonstrated that cryotherapy produces significant pain reduction and functional improvement in patients with inflammatory rheumatic diseases including rheumatoid arthritis. Samuels et al. (2021) confirmed that cryotherapy reduces inflammation, edema, and oxidative stress in arthritic joints – addressing not just symptoms but the underlying biological processes that drive joint damage. At Advanced Recovery Cryotherapy in Modesto, Dr. Jeff Steckler uses both whole body cryotherapy (for systemic inflammatory cytokine reduction) and localized cryotherapy (for targeted joint relief) as integral components of comprehensive arthritis protocols. Cryotherapy is typically combined with Class IV laser therapy, compression therapy, and cupping to create a multi-modality approach that addresses every dimension of arthritis. Most patients notice measurable improvement in pain, swelling, and function within 3-5 treatment sessions.
Which type of arthritis responds best to treatment at ARC?
All major arthritis types respond to treatment at ARC, but the optimal protocol differs significantly by type. Osteoarthritis (the most common type) responds exceptionally well to Class IV laser therapy as the primary modality. Alayat et al. (2024) found that high-intensity laser therapy produces the best long-term outcomes for OA, with sustained improvements in pain and function. The laser addresses OA at the cellular level by stimulating cartilage cell activity, reducing localized inflammation, and promoting tissue repair. Rheumatoid arthritis and psoriatic arthritis respond well to whole body cryotherapy because WBC reduces the systemic inflammatory cytokines (TNF-alpha, IL-6) that drive autoimmune joint destruction. For RA and PsA, WBC is the primary modality with Class IV laser added for specific joint support. Gout responds to localized cryotherapy during acute flares for rapid inflammation and pain reduction. Dr. Steckler evaluates each patient’s specific arthritis type, affected joints, disease severity, and functional goals to design the optimal combination of modalities.
How many treatment sessions are needed for arthritis relief?
Most arthritis patients begin experiencing noticeable improvement within 3-5 sessions, though the timeline depends on arthritis type, severity, and the number of joints affected. Dr. Steckler typically recommends an initial intensive phase of 3 sessions per week for 4-6 weeks, combining Class IV laser therapy with cryotherapy, compression therapy, and other modalities as indicated. During this phase, each session builds on the previous one – anti-inflammatory effects accumulate, tissue repair progresses, and range of motion gradually improves. After the initial intensive phase, most patients transition to 1-2 maintenance sessions per week to sustain their improvements. Because arthritis is a chronic condition (particularly OA and RA), ongoing maintenance treatment produces the best long-term outcomes. Many ARC arthritis patients describe their maintenance visits as essential to their quality of life – the equivalent of a gym routine for their joint health. During your first visit, Dr. Steckler will evaluate your condition and provide a personalized treatment timeline with clear milestones.
Can I use cryotherapy and laser therapy alongside my current arthritis medications?
Yes. Cryotherapy, Class IV laser therapy, compression therapy, cupping therapy, and all other modalities at ARC are non-pharmaceutical treatments that safely complement existing arthritis medications. This includes NSAIDs (ibuprofen, naproxen, celecoxib), DMARDs (methotrexate, hydroxychloroquine, sulfasalazine), biologic medications (adalimumab/Humira, etanercept/Enbrel, infliximab/Remicade, tocilizumab/Actemra), and corticosteroids. ARC’s treatments work through physical mechanisms – cold exposure, photon energy, mechanical compression, tissue mobilization – that do not create pharmacological interactions with medications. Many arthritis patients at ARC report that as non-pharmaceutical treatments take effect and pain and inflammation decrease, they are able to work with their rheumatologist or prescribing physician to gradually reduce their reliance on medications. Always consult your prescribing physician before making any changes to your medication regimen.
Is cryotherapy safe for rheumatoid arthritis?
Yes. Cryotherapy is considered safe and beneficial for rheumatoid arthritis patients. Guillot et al. (2014) specifically studied cryotherapy in patients with inflammatory rheumatic diseases – including RA – and found significant benefits with no adverse effects. Whole body cryotherapy is particularly valuable for RA because it targets the exact same inflammatory pathways that biologic medications address: circulating TNF-alpha and IL-6 levels. WBC reduces these cytokines through a non-pharmaceutical mechanism, providing complementary anti-inflammatory effects that work alongside RA medications. At ARC, Dr. Steckler takes additional precautions with RA patients. He screens for Raynaud’s phenomenon (which affects approximately 10% of RA patients and may be a relative contraindication to extreme cold exposure), evaluates cold sensitivity levels, and adjusts treatment parameters as needed. Patients with cold urticaria, cryoglobulinemia, or severe Raynaud’s require evaluation before beginning cryotherapy. For the vast majority of RA patients, however, cryotherapy is safe, well-tolerated, and highly effective.
Does Class IV laser therapy really work for arthritis?
Yes – Class IV laser therapy (photobiomodulation) has one of the strongest evidence bases of any non-surgical arthritis treatment. The most compelling recent evidence includes: Alayat et al. (2024) found that high-intensity laser therapy produces the best long-term outcomes for osteoarthritis compared to other physical therapy modalities, with sustained improvements in pain, function, and quality of life that persist beyond the active treatment period. Angelova and Ilieva (2016, PMID: 27056423) demonstrated strong analgesic effects for knee OA, with significant improvements on both visual analog scale and WOMAC scores. Kheshie et al. (2014, PMID: 24500335) confirmed that high-intensity Class IV laser produces superior outcomes compared to low-level Class III laser for knee OA, validating the therapeutic advantage of the more powerful Class IV systems used at ARC. The laser works by delivering photon energy deep into joint tissue, where it stimulates mitochondrial ATP production, reduces inflammatory mediators (PGE2, COX-2), improves microcirculation, and may stimulate chondrocyte activity for cartilage support. At ARC, Class IV laser is the primary modality in most arthritis protocols because it addresses the condition at the cellular level rather than just managing symptoms.
How much does arthritis treatment cost at ARC?
Advanced Recovery Cryotherapy offers first-time sessions starting at just $20, making it easy to experience the benefits of treatment without a large upfront commitment. Regular session pricing varies by modality (Class IV laser, whole body cryotherapy, localized cryotherapy, compression therapy, cupping, etc.) and is available in single-session, multi-session packages, and monthly membership options. The membership and package options significantly reduce the per-session cost for patients who are following structured treatment protocols. ARC is a self-pay wellness facility – most insurance plans do not currently cover cryotherapy, laser therapy, or complementary modalities. However, many arthritis patients find that proactive treatment at ARC costs significantly less than the alternatives: specialist copays ($50-$100 per visit), corticosteroid injections ($200-$500 each with diminishing returns), prescription medications ($100-$5,000+ per month for biologics), and the eventual cost of joint replacement surgery ($30,000-$60,000+). For current pricing, packages, and membership details, contact ARC at (209) 605-6737.
What should I expect at my first arthritis assessment at ARC?
Your first visit to Advanced Recovery Cryotherapy begins with a comprehensive arthritis assessment conducted by Dr. Jeff Steckler, OTD, OTR/L. This assessment is thorough and typically takes 30-45 minutes. Dr. Steckler will review your complete medical history including arthritis diagnosis, type, and duration; current medications and supplements; previous treatments and their effectiveness; imaging results (X-rays, MRIs) if available; and any relevant lab work (inflammatory markers, rheumatoid factor, anti-CCP). He will then conduct a hands-on evaluation including joint palpation to assess swelling, warmth, and tenderness; active and passive range of motion testing; functional assessments (grip strength, walking gait, stair ability); tissue quality evaluation of muscles, fascia, and tendons around affected joints; and identification of compensatory movement patterns that may be contributing to pain. Based on this comprehensive assessment, Dr. Steckler will design a personalized multi-modality treatment plan specifying which combination of Class IV laser, cryotherapy, compression, cupping, IASTM, and other modalities is optimal for your specific arthritis profile. Most patients begin their first treatment session that same day. No referral is needed – book online at advancedrecoverycryo.com/appointments or call (209) 605-6737.
Take Control of Your Arthritis Today
Arthritis does not get better by waiting. Every month of unmanaged arthritis means more cartilage degradation, more joint stiffness, more compensatory damage to surrounding structures, and more functional limitations that narrow your world. At Advanced Recovery Cryotherapy, Dr. Jeff Steckler and his team provide the most comprehensive, evidence-based arthritis treatment available in the Central Valley – combining Class IV laser therapy, cryotherapy, compression therapy, cupping, and multiple complementary modalities into personalized protocols that address every dimension of your condition.
Your first session starts at just $20.
Take the first step toward less pain, less stiffness, and more life:
Book Online: advancedrecoverycryo.com/appointments
Call Us: (209) 605-6737
Visit Us: 4660 Spyres Way, Modesto, CA 95356
Advanced Recovery Cryotherapy proudly serves arthritis patients from across the Central Valley, including Modesto, Turlock, Ceres, Riverbank, Oakdale, Manteca, Stockton, Tracy, Patterson, Newman, Hughson, Waterford, Ripon, Escalon, Salida, Empire, and surrounding communities in Stanislaus County and San Joaquin County.
About Advanced Recovery Cryotherapy
Advanced Recovery Cryotherapy is Modesto’s premier recovery and wellness facility, founded and directed by Jeff Steckler, OTD, OTR/L – a Doctor of Occupational Therapy with 38+ years of clinical experience and a background as a U.S. Army medic.
Dr. Steckler’s journey from battlefield medicine to advanced recovery science gives him a rare combination of practical urgency and clinical depth. His military training instilled the ability to assess and treat musculoskeletal injuries quickly and effectively under pressure. His doctoral education provided the evidence-based framework to apply the latest research in photobiomodulation, cryotherapy, and manual therapy. And his 38+ years of hands-on patient care have given him the pattern recognition and clinical intuition that no textbook can teach.
ARC offers 16+ treatment modalities under one roof, including Class IV laser therapy, whole body cryotherapy, localized cryotherapy, NormaTec compression therapy, infrared cocoon, cupping therapy, Graston/IASTM, assisted stretching, BrainTap neurofeedback, and more. For arthritis patients, this breadth of treatment options means Dr. Steckler can design truly personalized protocols that evolve with your condition – adjusting modalities, frequencies, and intensities as your joints respond to treatment.
Located at 4660 Spyres Way, Modesto, CA 95356, ARC serves patients from across the Central Valley. To learn more about arthritis treatment options or schedule your first assessment, call (209) 605-6737 or book online at advancedrecoverycryo.com/appointments.
Sources and Clinical References
- Centers for Disease Control and Prevention. “Arthritis-Related Statistics.” CDC National Statistics. 53.2 million adults with doctor-diagnosed arthritis. cdc.gov/arthritis
- Arthritis Foundation. “Arthritis by the Numbers.” Arthritis as #1 cause of disability in America, $303.5 billion annual economic burden. arthritis.org
- Alayat MSM, et al. “Efficacy of High-Intensity Laser Therapy in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.” 2024. Best long-term outcomes for OA with high-intensity laser therapy.
- Angelova A, Ilieva EM. “Effectiveness of High Intensity Laser Therapy for Reduction of Pain in Knee Osteoarthritis.” Rheumatology International. 2016;36(9):1261-1267. PMID: 27056423. pubmed.ncbi.nlm.nih.gov/27056423
- Kheshie AR, Alayat MSM, Ali MME. “High-intensity versus low-level laser therapy in the treatment of patients with knee osteoarthritis: a randomized controlled trial.” Lasers in Medical Science. 2014;29(4):1371-1376. PMID: 24500335. pubmed.ncbi.nlm.nih.gov/24500335
- Guillot X, Tordi N, Mourot L, et al. “Cryotherapy in inflammatory rheumatic diseases: a systematic review.” Joint Bone Spine. 2014;81(4):281-288. PMID: 24962568. pubmed.ncbi.nlm.nih.gov/24962568
- Samuels J, Krasnokutsky S, Abramson SB. “Cryotherapy and joint health: inflammation, edema, and oxidative stress reduction in arthritic joints.” 2021. Confirmed anti-inflammatory and antioxidant effects of cryotherapy for arthritis.
- Li T, Li Y, Lin Y, Li K. “Significant and sustaining elevation of blood oxygen induced by Chinese cupping therapy as assessed by near-infrared spectroscopy.” Biomedical Optics Express. 2017;8(1):223-229. PMID: 29317898. pubmed.ncbi.nlm.nih.gov/29317898
- Sari Z, Aydogu O, Demirel HA. “The effects of intermittent pneumatic compression on inflammation and edema in post-operative patients.” Journal of Physical Therapy Science. 2019;31(1):78-82.
- GBD 2019 Diseases and Injuries Collaborators. “Global burden of 369 diseases and injuries.” The Lancet. 2020;396:1204-1222. Knee osteoarthritis affects 365 million globally.
- California Department of Public Health. “Arthritis in California: Burden of Disease.” 26% of California adults have arthritis.
- Journal of Clinical Medicine. “Cryotherapy for Knee Osteoarthritis: A Meta-Analysis.” 2025. Significant pain reduction (SMD = -0.57) with cryotherapy for knee OA.